Top compounds associated with response to AL513412.1


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.066 0.04
mRNA tigecycline CTRPv2 pan-cancer AAC 0.12 0.04
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.04
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.1 0.04
mRNA hyperforin CTRPv2 pan-cancer AAC -0.086 0.04
mRNA nintedanib CTRPv2 pan-cancer AAC -0.086 0.04
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.084 0.04
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.069 0.04
mRNA 968 CTRPv2 pan-cancer AAC -0.16 0.04
mRNA decitabine CTRPv2 pan-cancer AAC 0.061 0.04
Download CSV